Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:15 PM
Ignite Modification Date:
2026-03-26 @ 3:15 PM
NCT ID:
NCT07374692
Eligibility Criteria:
* INCLUSION CRITERIA
* Participants must have advanced CNS tumors confirmed by a documented pathology report, including:
* recurrent isocitrate dehydrogenase (IDH)-wild-type high-grade glioma
* recurrent IDH-mutant gliomas
* other recurrent CNS tumors
* Participants must have been scheduled for a brain tumor biopsy or resection. Note: Scheduled brain tumor biopsy or resection must be at least 6 months after any previous radiation therapy, if applicable. All procedures are planned to take place at NIH.
* Age \>= 15 years.
* Ability of participant, parent/guardian, or Legally Authorized Representative (LAR) to understand and sign a written informed consent document.
EXCLUSION CRITERIA
None.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
15 Years
Maximum Age:
120 Years
Study:
NCT07374692
Study Brief:
Protocol Section:
NCT07374692